These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 29247718)

  • 1. Important signals regulating coronary artery angiogenesis.
    Shoeibi S; Mozdziak P; Mohammadi S
    Microvasc Res; 2018 May; 117():1-9. PubMed ID: 29247718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting tumor micro-environment for design and development of novel anti-angiogenic agents arresting tumor growth.
    Gacche RN; Meshram RJ
    Prog Biophys Mol Biol; 2013 Nov; 113(2):333-54. PubMed ID: 24139944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet-Derived Exosomes Affect the Proliferation and Migration of Human Umbilical Vein Endothelial Cells Via miR-126.
    Sun Y; Liu XL; Zhang D; Liu F; Cheng YJ; Ma Y; Zhou YJ; Zhao YX
    Curr Vasc Pharmacol; 2019; 17(4):379-387. PubMed ID: 29532758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Axitinib attenuates intraplaque angiogenesis, haemorrhages and plaque destabilization in mice.
    Van der Veken B; De Meyer GRY; Martinet W
    Vascul Pharmacol; 2018 Jan; 100():34-40. PubMed ID: 29079346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiogenic factors as potential drug target: efficacy and limitations of anti-angiogenic therapy.
    Gacche RN; Meshram RJ
    Biochim Biophys Acta; 2014 Aug; 1846(1):161-79. PubMed ID: 24836679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiogenesis--a new target for future therapy.
    Pandya NM; Dhalla NS; Santani DD
    Vascul Pharmacol; 2006 May; 44(5):265-74. PubMed ID: 16545987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of FGF2 in migration and tubulogenesis of endothelial progenitor cells in relation to pro-angiogenic growth factor production.
    Litwin M; Radwańska A; Paprocka M; Kieda C; Dobosz T; Witkiewicz W; Baczyńska D
    Mol Cell Biochem; 2015 Dec; 410(1-2):131-42. PubMed ID: 26314253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plaque neovascularization and antiangiogenic therapy for atherosclerosis.
    Doyle B; Caplice N
    J Am Coll Cardiol; 2007 May; 49(21):2073-80. PubMed ID: 17531655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. VEGF-A/VEGFR-2 and FGF-2/FGFR-1 but not PDGF-BB/PDGFR-β play important roles in promoting immature and inflammatory intraplaque angiogenesis.
    Mao Y; Liu X; Song Y; Zhai C; Zhang L
    PLoS One; 2018; 13(8):e0201395. PubMed ID: 30125282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apoptosis and angiogenesis are induced in the unstable coronary atherosclerotic plaque.
    Chen F; Eriksson P; Kimura T; Herzfeld I; Valen G
    Coron Artery Dis; 2005 May; 16(3):191-7. PubMed ID: 15818089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor escape from endogenous, extracellular matrix-associated angiogenesis inhibitors by up-regulation of multiple proangiogenic factors.
    Fernando NT; Koch M; Rothrock C; Gollogly LK; D'Amore PA; Ryeom S; Yoon SS
    Clin Cancer Res; 2008 Mar; 14(5):1529-39. PubMed ID: 18316578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting Angiogenesis in Cancer Therapy: Moving Beyond Vascular Endothelial Growth Factor.
    Zhao Y; Adjei AA
    Oncologist; 2015 Jun; 20(6):660-73. PubMed ID: 26001391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone morphogenetic proteins in tumour associated angiogenesis and implication in cancer therapies.
    Ye L; Jiang WG
    Cancer Lett; 2016 Oct; 380(2):586-597. PubMed ID: 26639195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tanshinone IIA inhibits β-catenin/VEGF-mediated angiogenesis by targeting TGF-β1 in normoxic and HIF-1α in hypoxic microenvironments in human colorectal cancer.
    Sui H; Zhao J; Zhou L; Wen H; Deng W; Li C; Ji Q; Liu X; Feng Y; Chai N; Zhang Q; Cai J; Li Q
    Cancer Lett; 2017 Sep; 403():86-97. PubMed ID: 28602978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. VEGF and FGF-2: Promising targets for the treatment of respiratory disorders.
    Laddha AP; Kulkarni YA
    Respir Med; 2019 Sep; 156():33-46. PubMed ID: 31421589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiogenesis: mechanistic insights, neovascular diseases, and therapeutic prospects.
    Battegay EJ
    J Mol Med (Berl); 1995 Jul; 73(7):333-46. PubMed ID: 8520966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiogenesis in rheumatoid arthritis.
    Maruotti N; Cantatore FP; Crivellato E; Vacca A; Ribatti D
    Histol Histopathol; 2006 May; 21(5):557-66. PubMed ID: 16493585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Harmine inhibits tumour specific neo-vessel formation by regulating VEGF, MMP, TIMP and pro-inflammatory mediators both in vivo and in vitro.
    Hamsa TP; Kuttan G
    Eur J Pharmacol; 2010 Dec; 649(1-3):64-73. PubMed ID: 20858484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. (2-Hydroxypropyl)-β-Cyclodextrin Is a New Angiogenic Molecule for Therapeutic Angiogenesis.
    Qi X; Yuan Y; Xu K; Zhong H; Zhang Z; Zhai H; Guan G; Yu G
    PLoS One; 2015; 10(5):e0125323. PubMed ID: 25944736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Melatonin as an angiogenesis inhibitor to combat cancer: Mechanistic evidence.
    Goradel NH; Asghari MH; Moloudizargari M; Negahdari B; Haghi-Aminjan H; Abdollahi M
    Toxicol Appl Pharmacol; 2017 Nov; 335():56-63. PubMed ID: 28974455
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.